Hans Princen
0000-0002-7206-1596
TNO Pharma
6 papers found
Refreshing results…
Atorvastatin attenuates diet-induced non-alcoholic steatohepatitis in ApoE*3-Leiden mice by reducing hepatic inflammation
The tyrosine kinase inhibitor nilotinib targets the discoidin domain receptor DDR2 in calcific aortic valve stenosis
Effects of mineral oil administration on the pharmacokinetics, metabolism and pharmacodynamics of atorvastatin and pravastatin in mice and dogs
Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not?
Effects of Inhibition or Deletion of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) on Intracerebral Hemorrhage Volumes in Mice
Anti-PCSK9 antibodies inhibit pro-atherogenic mechanisms in APOE*3Leiden.CETP mice
Missing publications? Search for publications with a matching author name.